Eye Pressure Medicine for Glaucoma or High Eye Pressure
Part of Eyes & vision clinical trials.
This study tests a new eye drop medicine (DNN.31.19.026) to lower pressure inside the eye for people with glaucoma or ocular hypertension. The goal is to see if it works safely when combined with other eye pressure medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with glaucoma or ocular hypertension (high pressure in the eye)
- You need treatment to lower eye pressure and may benefit from using two eye drop medicines together
- You have had prior glaucoma treatment (not a newly diagnosed patient with no treatment history)
- You have not had eye surgery or laser eye treatment within the past 6 months
- You do not have uncontrolled heart, lung, liver, kidney, or diabetes conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
This study tests whether three different eye drop treatments (netarsudil, latanoprost, or both together) can improve blood flow to the white part of the eye and the retina. It may help people with high eye pressure or who are glaucoma suspects better understand how these treatments work.
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
This study tests a new medication ring that sits in your eye to treat glaucoma or high eye pressure. The ring slowly releases medicine over time and may help lower pressure in your eye more safely and conveniently than daily eye drops.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
Hear when a new Ocular Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.